Pulsed Field Ablation market projected to reach USD 2,127.9 million by 2032, with CAGR of 38.90%
From GlobeNewswire: 2025-03-20 10:00:00
The Pulsed Field Ablation Market was valued at USD 110.8 million in 2023 and is projected to reach USD 2127.9 million by 2032, with a CAGR of 38.90%. Factors like the rise in atrial fibrillation cases and advancements in minimally invasive cardiac procedures are fueling the demand for PFA systems globally.
Pulsed Field Ablation is a non-thermal ablation technique that enhances treatment precision and efficiency for cardiac arrhythmias, especially atrial fibrillation. This method allows selective cardiac tissue ablation with high-energy electric fields, reducing collateral damage and procedure durations. The market growth is driven by the increasing incidence of atrial fibrillation and technological advancements in ablation devices.
Key companies in the Pulsed Field Ablation market include Medtronic, Boston Scientific, Abbott, Philips Healthcare, and Johnson & Johnson, among others. These companies offer a range of products like PFA systems, ablation catheters, and EP mapping systems to cater to the growing demand for advanced cardiac arrhythmia treatment options.
The catheter segment led the Pulsed Field Ablation market in 2023, accounting for 89.3% of the revenue share. Newer catheters with improved design features and integrated mapping systems enhance accuracy and safety, reducing procedural times and complications. Catheters are expected to maintain dominance with manufacturers focusing on next-generation devices for better patient outcomes.
In 2023, the atrial fibrillation segment held the largest market share of 97.2% due to the high prevalence of AF globally. PFA selectively ablates myocardial tissue without thermal damage, making it a promising therapy for AF. The rising geriatric population and related complications are driving the segment’s growth, with potential applications in other arrhythmia types.
Inpatient facilities accounted for 90.8% of the market share in 2023, as PFA procedures are mainly performed in hospitals or specialized cardiac centers due to the need for sophisticated infrastructure and skilled personnel. These facilities offer advanced monitoring systems and post-procedure care for complex cardiac cases, contributing to the segment’s dominance. The Pulsed Field Ablation (PFA) market is growing due to the trend towards outpatient cardiac procedures in North America and Europe. PFA is ideal for ambulatory surgical centers, with improved recovery times and cost-effective procedures. North America leads the market, driven by the high prevalence of atrial fibrillation and strong government support for cardiac care. The Asia-Pacific region is expected to be the fastest-growing market, with investments in healthcare infrastructure and a focus on minimizing cardiovascular disease burden.
Recent developments include Medtronic’s PulseSelect™ PFA System and Boston Scientific’s FARAPULSE™ PFA System, both receiving approvals for atrial fibrillation treatment. The global PFA market is expected to continue growing, with opportunities for market expansion in Asia-Pacific as technology becomes more affordable and available.
For more information on the Pulsed Field Ablation market and to access the complete report, visit the SNS Insider website. SNS Insider is a leading market research and consulting agency, providing clients with current, accurate market data and insights to make confident decisions in changing circumstances. Contact [email protected] for customized research or further inquiries.
Read more at GlobeNewswire: Pulsed Field Ablation Market to Hit USD 2,127.9 Million by